Google
 

Tuesday, December 11, 2007

ad2

Currently about 20 products including conventional and recombinant vacancies, Anti cancer bio-therapeutics, diagnostics using recombinant antigens and natural thrombolites with high market potential are in Cadila Pharmaceuticals' Biotechnology basket. A sterling example is Immuvac, a potent, unique Immunomodulator developed for the first time in the world.

No comments: